Primo medical group announces sale of its spin-off co arthrosurface, to anika therapeutics

Announcing sale of its spin-off co arthrosurface, to anika therapeutics.anika will acquire all outstanding shares of arthrosurface in exchange for total consideration of $100 million.deal price consists of an upfront payment of approximately $60 million in cash.
ANIK Ratings Summary
ANIK Quant Ranking